At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Zenith® p-Branch® in combination with the Atrium iCAST™ covered stentsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Zenith® p-Branch® Pivotal Study
In Brief
A clinical study evaluating Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents for Aortic Aneurysm Abdominal. Completed, enrolled 80 participants across 27 sites.
Detailed Summary
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm Abdominal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartAug 2015
Primary CompletionApr 2021
Study CompletionJan 2025
TodayJul 2026
First PostedMar 24, 2015
Enrollment StartAug 1, 2015
Primary CompletionApr 1, 2021
Study CompletionJan 28, 2025
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 11.3 years ago
Interventions
Zenith® p-Branch® in combination with the Atrium iCAST™ covered stentsdevice
Instead of making a large incision in the abdomen, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.